Does the media refer more to CLPT or MBOT?

In the previous week, ClearPoint Neuro had 3 more articles in the media than Microbot Medical. MarketBeat recorded 6 mentions for ClearPoint Neuro and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.52 beat ClearPoint Neuro's score of 0.14 indicating that Microbot Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ClearPoint Neuro 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to SI or MBOT?

In the previous week, Shoulder Innovations had 27 more articles in the media than Microbot Medical. MarketBeat recorded 30 mentions for Shoulder Innovations and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.52 beat Shoulder Innovations' score of 0.29 indicating that Microbot Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Shoulder Innovations 12 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor DCTH or MBOT?

In the previous week, Delcath Systems had 16 more articles in the media than Microbot Medical. MarketBeat recorded 19 mentions for Delcath Systems and 3 mentions for Microbot Medical. Delcath Systems' average media sentiment score of 0.91 beat Microbot Medical's score of 0.52 indicating that Delcath Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 5 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ELMD or MBOT?

In the previous week, Microbot Medical had 2 more articles in the media than Electromed. MarketBeat recorded 3 mentions for Microbot Medical and 1 mentions for Electromed. Electromed's average media sentiment score of 1.54 beat Microbot Medical's score of 0.52 indicating that Electromed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Electromed 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Microbot Medical (MBOT) Competitors

$1.94 +0.05 (+2.38%)

As of 04:00 PM Eastern

Compare

MBOT vs. CLPT, SI, DCTH, ELMD, and CV

Should you buy Microbot Medical stock or one of its competitors? Microbot Medical's main competitors and comparable companies include ClearPoint Neuro (CLPT), Shoulder Innovations (SI), Delcath Systems (DCTH), Electromed (ELMD), and CapsoVision (CV). Companies are selected based on similarities in market, industry, and size.

How does Microbot Medical compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

ClearPoint Neuro has a beta of 1.24, meaning that its share price is 24% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.06, meaning that its share price is 6% more volatile than the broader market.

In the previous week, ClearPoint Neuro had 3 more articles in the media than Microbot Medical. MarketBeat recorded 6 mentions for ClearPoint Neuro and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.52 beat ClearPoint Neuro's score of 0.14 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ClearPoint Neuro	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ClearPoint Neuro currently has a consensus price target of $25.67, suggesting a potential upside of 76.16%. Microbot Medical has a consensus price target of $6.63, suggesting a potential upside of 242.38%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts clearly believe Microbot Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Microbot Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

Microbot Medical has lower revenue, but higher earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	12.02	-$25.54M	-$1.18	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Microbot Medical has a net margin of 0.00% compared to ClearPoint Neuro's net margin of -81.76%. Microbot Medical's return on equity of -21.84% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-81.76%	-188.09%	-40.88%
Microbot Medical	N/A	-21.84%	-20.71%

Summary

Microbot Medical beats ClearPoint Neuro on 10 of the 15 factors compared between the two stocks.

How does Microbot Medical compare to Shoulder Innovations?

Shoulder Innovations (NYSE:SI) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment.

16.3% of Microbot Medical shares are owned by institutional investors. 29.0% of Shoulder Innovations shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Microbot Medical has a net margin of 0.00% compared to Shoulder Innovations' net margin of -58.33%. Microbot Medical's return on equity of -21.84% beat Shoulder Innovations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shoulder Innovations	-58.33%	-23.61%	-19.53%
Microbot Medical	N/A	-21.84%	-20.71%

Microbot Medical has lower revenue, but higher earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shoulder Innovations	$47.32M	9.24	-$40.36M	-$1.92	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

In the previous week, Shoulder Innovations had 27 more articles in the media than Microbot Medical. MarketBeat recorded 30 mentions for Shoulder Innovations and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.52 beat Shoulder Innovations' score of 0.29 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shoulder Innovations	12 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Shoulder Innovations currently has a consensus price target of $23.50, indicating a potential upside of 11.96%. Microbot Medical has a consensus price target of $6.63, indicating a potential upside of 242.38%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts clearly believe Microbot Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63
Microbot Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

Microbot Medical beats Shoulder Innovations on 10 of the 15 factors compared between the two stocks.

How does Microbot Medical compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 19.4% of Delcath Systems shares are held by company insiders. Comparatively, 4.7% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Delcath Systems had 16 more articles in the media than Microbot Medical. MarketBeat recorded 19 mentions for Delcath Systems and 3 mentions for Microbot Medical. Delcath Systems' average media sentiment score of 0.91 beat Microbot Medical's score of 0.52 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	5 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Delcath Systems currently has a consensus price target of $23.17, indicating a potential upside of 38.97%. Microbot Medical has a consensus price target of $6.63, indicating a potential upside of 242.38%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts plainly believe Microbot Medical is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Microbot Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

Delcath Systems has a net margin of 0.56% compared to Microbot Medical's net margin of 0.00%. Delcath Systems' return on equity of 0.46% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.56%	0.46%	0.42%
Microbot Medical	N/A	-21.84%	-20.71%

Delcath Systems has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market.

Delcath Systems has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	6.79	$2.70M	$0.01	1,667.00
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Summary

Delcath Systems beats Microbot Medical on 12 of the 16 factors compared between the two stocks.

How does Microbot Medical compare to Electromed?

Electromed (NYSE:ELMD) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

Electromed presently has a consensus price target of $37.50, suggesting a potential downside of 11.93%. Microbot Medical has a consensus price target of $6.63, suggesting a potential upside of 242.38%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts clearly believe Microbot Medical is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Microbot Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

In the previous week, Microbot Medical had 2 more articles in the media than Electromed. MarketBeat recorded 3 mentions for Microbot Medical and 1 mentions for Electromed. Electromed's average media sentiment score of 1.54 beat Microbot Medical's score of 0.52 indicating that Electromed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

40.8% of Electromed shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 10.5% of Electromed shares are held by company insiders. Comparatively, 4.7% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Electromed has a net margin of 11.34% compared to Microbot Medical's net margin of 0.00%. Electromed's return on equity of 15.71% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Microbot Medical	N/A	-21.84%	-20.71%

Electromed has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market.

Electromed has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$71.75M	4.91	$5.15M	$1.17	36.39
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Summary

Electromed beats Microbot Medical on 11 of the 16 factors compared between the two stocks.

How does Microbot Medical compare to CapsoVision?

Microbot Medical (NASDAQ:MBOT) and CapsoVision (NASDAQ:CV) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

Microbot Medical has higher earnings, but lower revenue than CapsoVision. Microbot Medical is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
CapsoVision	$13.55M	24.63	-$25.32M	-$2.34	N/A

16.3% of Microbot Medical shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Comparatively, 2.3% of CapsoVision shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Microbot Medical has a net margin of 0.00% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
CapsoVision	-198.87%	N/A	-136.03%

Microbot Medical presently has a consensus target price of $6.63, indicating a potential upside of 242.38%. CapsoVision has a consensus target price of $8.50, indicating a potential upside of 27.25%. Given Microbot Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Microbot Medical is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Microbot Medical had 3 more articles in the media than CapsoVision. MarketBeat recorded 3 mentions for Microbot Medical and 0 mentions for CapsoVision. Microbot Medical's average media sentiment score of 0.52 beat CapsoVision's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Microbot Medical	Positive
CapsoVision	Neutral

Summary

Microbot Medical beats CapsoVision on 12 of the 15 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MBOT vs. The Competition

Export

Metric	Microbot Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$129.97M	$5.79B	$7.06B	$12.95B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	-7.44	24.71	269.75	24.73
Price / Sales	N/A	67.44	652.34	108.63
Price / Cash	N/A	33.55	28.89	37.44
Price / Book	1.68	6.21	11.27	6.42
Net Income	-$13.14M	$147.87M	$3.45B	$347.12M
7 Day Performance	9.32%	3.40%	3.56%	2.48%
1 Month Performance	2.38%	1.66%	-0.58%	-1.04%
1 Year Performance	-37.38%	6.26%	77.52%	23.22%

Microbot Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MBOT Microbot Medical	2.1907 of 5 stars	$1.94 +2.4%	$6.63 +242.4%	-38.8%	$129.97M	N/A	N/A	20	Upcoming Earnings
CLPT ClearPoint Neuro	2.6528 of 5 stars	$14.60 +3.4%	$23.00 +57.5%	+31.3%	$423.45M	$36.97M	N/A	110	Earnings Report Analyst Downgrade
SI Shoulder Innovations	2.562 of 5 stars	$20.99 +2.8%	$21.00 +0.1%	+66.7%	$423.27M	$47.32M	N/A	61	News Coverage Analyst Forecast Insider Trade
DCTH Delcath Systems	3.1095 of 5 stars	$11.94 -2.3%	$22.17 +85.7%	+50.9%	$421.86M	$90.44M	1,194.00	60	Earnings Report Analyst Forecast Analyst Revision
ELMD Electromed	1.2156 of 5 stars	$39.86 +3.8%	$37.50 -5.9%	+126.3%	$330.04M	$71.75M	53.15	160	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MBOT) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Microbot Medical (MBOT) Competitors

MBOT vs. CLPT, SI, DCTH, ELMD, and CV

How does Microbot Medical compare to ClearPoint Neuro?

Summary

How does Microbot Medical compare to Shoulder Innovations?

Summary

How does Microbot Medical compare to Delcath Systems?

Summary

How does Microbot Medical compare to Electromed?

Summary

How does Microbot Medical compare to CapsoVision?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT vs. The Competition

Microbot Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Microbot Medical (MBOT) Competitors

MBOT vs. CLPT, SI, DCTH, ELMD, and CV

How does Microbot Medical compare to ClearPoint Neuro?

Do insiders and institutionals hold more shares of CLPT or MBOT?

Which has more risk and volatility, CLPT or MBOT?

Does the media refer more to CLPT or MBOT?

Do analysts recommend CLPT or MBOT?

Which has higher earnings and valuation, CLPT or MBOT?

Is CLPT or MBOT more profitable?

Summary

How does Microbot Medical compare to Shoulder Innovations?

Do institutionals and insiders believe in SI or MBOT?

Is SI or MBOT more profitable?

Which has higher valuation and earnings, SI or MBOT?

Does the media refer more to SI or MBOT?

Do analysts prefer SI or MBOT?

Summary

How does Microbot Medical compare to Delcath Systems?

Do insiders & institutionals believe in DCTH or MBOT?

Does the media favor DCTH or MBOT?

Do analysts recommend DCTH or MBOT?

Is DCTH or MBOT more profitable?

Which has more volatility and risk, DCTH or MBOT?

Which has stronger valuation and earnings, DCTH or MBOT?

Summary

How does Microbot Medical compare to Electromed?

Do analysts rate ELMD or MBOT?

Does the media refer more to ELMD or MBOT?

Do insiders and institutionals have more ownership in ELMD or MBOT?

Is ELMD or MBOT more profitable?

Which has more volatility and risk, ELMD or MBOT?

Which has higher earnings and valuation, ELMD or MBOT?

Summary

How does Microbot Medical compare to CapsoVision?

Which has better earnings & valuation, MBOT or CV?

Do insiders & institutionals believe in MBOT or CV?

Is MBOT or CV more profitable?

Do analysts prefer MBOT or CV?

Does the media prefer MBOT or CV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT vs. The Competition

Microbot Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools